Pain medicine

Durable multimodal and holistic response for physiologic closed-loop spinal cord stimulation supported by objective evidence from the EVOKE double-blind randomized controlled trial

Reg Anesth Pain MedPublished Secondary analysis of the EVOKE randomised trial

Primary result · Holistic respondersResult — go to the resultAbsolute risk difference 22.4% 95% CI 6.4%–38.4%

Authors' conclusion

The results of this study suggest that closed-loop spinal cord stimulation can provide sustained clinically meaningful improvements in multiple domains and provide holistic improvement in the long-term for patients with chronic refractory pain.

Study context

Population
Patients with chronic refractory pain
Participants
67 vs 67
Comparison
ECAP-controlled closed-loop vs open-loop spinal cord stimulation
  • Closed-loopn = 67
  • Open-loopn = 67reference
Primary endpoint
Holistic treatment response (at least one minimal clinical important difference in all domains impaired at baseline: pain intensity, physical function, health-related quality of life, sleep quality, emotional function)
Follow-up
24 months
Methodological detailsmulticentre, participant, investigator, and outcome assessor-blinded, parallel-arm
  • Multicentre
  • Participant, investigator, and outcome assessor-blinded
  • Parallel-arm

Primary result

Holistic responders

Absolute risk difference

22.4%

95% CI 6.4%–38.4%

P = 0.012

By group

Closed-loop vs Open-loop
absolute risk difference 22.4% (95% CI 6.4%–38.4%); P = 0.012

As reported in the abstract

Further findings

OutcomeMean difference (95% CI)P value
Cumulative responder score (total minimal clinical important differences across all domains) · 24 monthsSignificantly greater for closed-loop at all time points3.4 (1.3–5.5)P = 0.002

Accuracy of neural activation

Three times more accurate in closed-loop
P < 0.001 at all time points

Original publication

Durable multimodal and holistic response for physiologic closed-loop spinal cord stimulation supported by objective evidence from the EVOKE double-blind randomized controlled trial. Reg Anesth Pain Med. Published 25 July 2023. doi:10.1136/rapm-2023-104639

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.